The collaboration accelerates collective impact in tackling the greatest challenges in global health
The World Health Organization (WHO) and the International Development Innovation Alliance (IDIA) have agreed to renew their strategic collaborative agreement to support the scaling of health innovations to the end of 2023 to jointly accelerate health impact.
The collaboration was established in the beginning of 2021 to create a shared agenda and enable close collaboration and complementarity between the two entities to promote and facilitate the demand, supply, assessment, and scale-up of health innovations for the benefit of low- and middle-income countries. The collaboration accelerates collective impact in tackling the greatest challenges in global health.
Collaboration between IDIA members and WHO covers the following five areas:
Innovation demand: Jointly collaborate in support of WHO Member States to enhance the identification and articulation of demand for innovation responding to national health needs and priorities and global targets.
Innovation supply: IDIA member agencies will contribute relevant innovations from their collective pipelines to meet the demand and innovation in health priorities articulated by WHO Member States.
Innovation assessment: WHO and IDIA will share expertise and tools to support the efficient assessment and clustering of scale-ready innovations surfaced through the supply pipeline.
Innovation scale-up: Work together to identify specific opportunities to support the demand-led scale-up of health innovations for the benefit of WHO Member States in collaboration with non-state actors and members of the international development community, as appropriate.
Innovation and scaling skill development: Join forces to support the continuous development of innovation and scaling knowledge and skills among WHO staff (HQ, regional and local), Member States and development partners as may be appropriate.